C. Phelan

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus
20250 citationsauthor #337
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis
20235 citationsauthor #31
WHOLE EXOME SEQUENCING IN A FOUNDER POPULATION IDENTIFIES NOVEL OVARIAN CANCER SUSCEPTIBILITY LOCI
20190 citationsauthor #1
Shared heritability and functional enrichment across six solid cancers
201994 citationsauthor #225
Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.
201935 citationsauthor #6
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.
201844 citationsauthor #79
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.
201859 citationsauthor #93
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.
201837 citationsauthor #107
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.
201826 citationsauthor #19
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology
20184 citationsauthor #109
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study
201815 citationsauthor #104
Abstract 420: Targeted deep sequencing of mitochondrial DNA in epithelial ovarian carcinomas
20180 citationsauthor #9
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility
201811 citationsauthor #149
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
201720 citationsauthor #60
Genome-wide significant associations of common low penetrance single nucleotide polymorphisms with risk of mucinous ovarian carcinoma
20170 citationsauthor #4
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
2017361 citationsauthor #326
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
201748 citationsauthor #1
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia
201730 citationsauthor #28
miRNAs associated with prostate cancer risk and progression
2017111 citationsauthor #7
Abstract 2293: Oligomenorrhea, polycystic ovary syndrome, and risk of ovarian cancer histotypes, evidence from the Ovarian Cancer Association Consortium
20171 citationsauthor #11
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium
201733 citationsauthor #23
Characterization of germline and tumor genomic profile in unselected young black breast cancer patients.
20170 citationsauthor #10
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies
201775 citationsauthor #22
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.
201674 citationsauthor #97
Abstract B27: Investigation of small GTPase genes in epithelial ovarian cancer.
20160 citationsauthor #14
Abstract PR15: MYC distal enhancers underlie ovarian cancer susceptibility in the 8q24.21 locus.
20161 citationsauthor #10
randomization Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study
20160 citationsauthor #81
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.
2016181 citationsauthor #33
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration
201611 citationsauthor #84
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
2016151 citationsauthor #199
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
2016110 citationsauthor #93
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
20164 citationsauthor #162
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
201681 citationsauthor #90
Association of breast cancer risk in BRCA 1 and BRCA 2 mutation carriers with genetic variants showing differential allelic expression
20160 citationsauthor #56
Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer
201610 citationsauthor #62
Chemoprevention in African American Men With Prostate Cancer.
20164 citationsauthor #7
African American men at high risk for prostate cancer . Chemoprevention in African American Men With Prostate Cancer
20160 citationsauthor #7
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3
201622 citationsauthor #119
A targeted genetic association study of epithelial ovarian cancer susceptibility
20167 citationsauthor #49
Correction: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer
20165 citationsauthor #51
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes
20160 citationsauthor #80
seXY: a tool for sex inference from genotype arrays
20165 citationsauthor #7
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
201620 citationsauthor #249
Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci
20166 citationsauthor #16
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.
201618 citationsauthor #72
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
201640 citationsauthor #177
Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170
201620 citationsauthor #206
Mendelian randomization Association of vitamin D levels and risk of ovarian cancer : a Mendelian randomization study
20160 citationsauthor #80
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus
201690 citationsauthor #337
The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
201628 citationsauthor #9
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in $\small \textit{BRCA1}$ and $\small \textit{BRCA2}$ Mutation Carriers
20161 citationsauthor #102
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers
2016317 citationsauthor #57
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes
201629 citationsauthor #89
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
201611 citationsauthor #102
Abstract A50: Mitochondrial metabolism gene variants are associated with risk and survival in epithelial ovarian cancer (EOC)
20160 citationsauthor #10
Telomere structure and maintenance gene variants and risk of five cancer types
201653 citationsauthor #58
PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS
2016173 citationsauthor #298
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
2016110 citationsauthor #173
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer
201561 citationsauthor #119
BRCA1 and BRCA2 mutations and the risk for colorectal cancer
201597 citationsauthor #2
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
201529 citationsauthor #107
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
201521 citationsauthor #115
Abstract B67: Effect of polyphenon E on progression to prostate cancer after diagnosis of high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation in African American men
20150 citationsauthor #4
A high frequency of BRCA mutations in young black women with breast cancer residing in Florida
2015113 citationsauthor #5
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
2015841 citationsauthor #159
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
201579 citationsauthor #82
Abstract 4635: Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility
20150 citationsauthor #15
Abstract 4633: Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk
20150 citationsauthor #16
Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)
201529 citationsauthor #155
Abstract 4634: Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk
20150 citationsauthor #15
Common variants at the CHEK 2 gene locus and risk of epithelial ovarian cancer
20152 citationsauthor #75
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
201533 citationsauthor #204
Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
201523 citationsauthor #157
Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.
201566 citationsauthor #36
Genome-wide significant risk associations for mucinous ovarian carcinoma (vol 47, pg 888, 2015)
20151 citationsauthor #7
Genome-wide significant risk associations for mucinous ovarian carcinoma
201584 citationsauthor #8
Recurrent BRCA 1 and BRCA 2 Mutations inMexican Women with Breast Cancer
20156 citationsauthor #11
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk
201537 citationsauthor #105
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
20150 citationsauthor #204
Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome
201422 citationsauthor #22
Abstract B49: Androgen receptor CAG repeat length association with prostate cancer risk in obese and non-obese African American men
20140 citationsauthor #4
Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers
201438 citationsauthor #6
Variation in NFk B Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer
20140 citationsauthor #90
Recurrent BRCA1 and BRCA2 Mutations in Mexican Women with Breast Cancer
201438 citationsauthor #11
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
201412 citationsauthor #120
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
20140 citationsauthor #181
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
2014248 citationsauthor #115
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.
201448 citationsauthor #62
Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer
201411 citationsauthor #82
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
201464 citationsauthor #181
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
2014122 citationsauthor #175
Abstract 3283: GWAS identifies risk variants for mucinous ovarian carcinoma
20140 citationsauthor #3
Differences in BRCA counseling and testing practices based on ordering provider type
201453 citationsauthor #6
Abstract 946: Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk
20140 citationsauthor #13
Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
201429 citationsauthor #174
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17 q 21 . 31
201313 citationsauthor #163
Kernel canonical correlation analysis for assessing gene–gene interactions and application to ovarian cancer
201338 citationsauthor #6
Abstract 3644: Variation in transmembrane transport genes influence epithelial ovarian cancer risk and histopathologic subtype.
20130 citationsauthor #19
Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome
201324 citationsauthor #84
Variation in HNF1B and Obesity May Influence Prostate Cancer Risk in African American Men: A Pilot Study
201318 citationsauthor #4

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT